Wisner Baum, JOTO PR Disruptors™’ Latest Client, Leads the Fight for Transparency and Justice
JOTO PR Disruptors™ has signed Wisner Baum LLP, a leading Los Angeles plaintiff firm, to amplify its voice on corporate …
1840 & Company, JOTO PR Disruptors™’ New Client, Bridges the Global Skills Gap
JOTO PR Disruptors™ has signed 1840 & Company, a global outsourcing and staffing leader, to drive visibility around …
The Next Public Health Crisis: Filthy Phones are Dirtier Than Toilet Seats - and More Dangerous
With the COVID-19 pandemic, hygiene awareness soared, but one major germ carrier was, and still is, overlooked: our phon …
Wisner Baum Calls for FDA Accountability as Toxic Metals Remain in Baby Food Products
Wisner Baum LLP is leading the fight against toxic baby food contamination as new recalls highlight ongoing risks of ear …
.jpg)
From Burnout to Breakthrough: EasyPA's Physician-Built AI Takes on Antiquated Prior Authorization
The growing demands on America’s healthcare system are colliding with an overburdened workforce, and prior authorization …
Retail Giants Abandon Battery-Powered ESLs--Wireless Power Unlocks Profitability and Scale
With global ESL adoption surging, Powercast’s RF wireless power technology makes it possible for U.S. retailers to scale …
Big Tech Built Complexity, Silent Partner Built Sales: Why Dealers Are Switching to Niche AI
Big tech's promise to revolutionize auto dealerships with AI has fallen flat, with productivity stagnating despite massi …
Tariffs Revive U.S. Manufacturing, But Nearshore Talent Powers Service Growth
As renewed tariffs revive domestic manufacturing, more dependence on nearshore and offshore services are key to reshapin …
Sleep Apnea Economic Burden in U.S. Exceeds $150B Annually--Vivos' Novel Solution Can Help
Obstructive sleep apnea (OSA) is a hidden driver of chronic disease and skyrocketing healthcare costs, with untreated ca …
First Ascent Biomedical Reports 83% Patient Benefit Rate Using Functional Precision Medicine Platform
First Ascent Biomedical is transforming cancer care with a novel platform that combines patient-derivedtesting, genomic …
